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TPRD1
PHARMACOECONOMIC ANALYSIS OF WARFARIN VERSUS ENOXAPARIN USED PROPHYLACTICALLY IN HIP SURGERY
Egan T Office of Professional Programs, University of the Sciences in Philadelphia and Clinical Pharmacotherapeutics, Inc., Philadelphia, PA, USA About 270,000 surgeries for total or partial hip replacement are performed annually in the United States. Patients not receiving prophylaxis agents result in an unacceptably high incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE). The primary agents used to prevent these complications are warfarin and low molecular weight heparins. OBJECTIVES: This study examined the cost and outcomes of hip surgery patients seen at Graduate Hospital from October 1994 to September 1995. METHODS: Economic and clinical outcomes data were collected respectively for patients undergoing hip surgery at Graduate Hospital in Philadelphia. The data were analyzed utilizing a risk adjusted outcome program developed for the Corporate Hospital Rating Project. Direct costs were calculated using Medicare cost reporting data by the hospital's finance department. RESULTS: Fifty-three patients were analyzed. Four received both enoxaparin and warfarin, one received neither. These patients were excluded from the analysis. Results indicate the total direct cost ($6860 versus $10,320), LOS (6.6d versus 10.5d) and complication rate (39.6% versus 50.7%) were lower with warfarin versus enoxaparin. Risk adjusted data also favored warfarin. There was no evidence of DVT or PE in either group during the 6-month follow-up period after discharge. CONCLUSIONS: The purported advantages of enoxaparin over warfarin were not seen in our institution. Although postsurgical adhesions following general abdominal surgery are directly responsible for negative clinical outcomes that require additional medical management and surgical re-intervention (and concomitant costs), the magnitude of these outcomes is not readily understood. Previous studies have been primarily case series in academic centers. OBJECTIVE: We sought to establish the incidence of smallbowel obstruction, adhesiolysis for obstruction, and additional abdominal surgery following open colorectal and general surgery among the elderly across all settings.
TPRD2
INCIDENCE OF SMALL-BOWEL OBSTRUCTION AND ADHESIOLYSIS FOLLOWING OPEN COLORECTAL AND GENERAL SURGERY
METHODS:
We conducted a retrospective cohort study using patient-specific HCFA data to evaluate a random 5% sample of all Medicare patients undergoing surgery in 1993. Of these, 18,912 patients had an index abdominal procedure. Two-year follow-up data documented outcomes of hospitalizations with obstruction, adhesiolysis for obstruction, and/or additional open colorectal or general surgery.
